NICE decisions on treatment of ovarian cancer and ischaemic heart disease released

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.263, 2000-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcium antagonists in the treatment of hypertension in patients with ischaemic heart disease

By Rosendorff Clive  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1535-1541

Informa Healthcare

Access to resources Recommend Favorite

Recent NICE decisions for cancer drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Prevention and treatment of ischaemic heart disease are both important in patients with chronic kidney disease

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 6, 2009-06 ,pp. : 19-21

Adis International

Access to resources Recommend Favorite

UK NICE issues new lung cancer, ovarian cancer guidelines

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 628, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Current treatment for ovarian cancer

By Eltabbakh G.H.   Awtrey C.S.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 109-124

Informa Healthcare

Access to resources Recommend Favorite